The lancet oncology

• Latest
• Best
• Search…

• The lancet oncology · Aug 2013

  Multicenter Study

  Dose-dense cisplatin-based chemotherapy and surgery for children with high-risk hepatoblastoma (SIOPEL-4): a prospective, single-arm, feasibility study.

  The objective of this study was to establish the efficacy and safety of a new treatment regimen consisting of dose-dense cisplatin-based chemotherapy and radical surgery in children with high-risk hepatoblastoma. ⋯ Cancer Research UK and Cancer Research Switzerland/Oncosuisse.

  read on… or not…

• The lancet oncology · Aug 2013

  Editorial

  Cleaning our polluted skies.

  no abstract available

  keep reading… mark as read…

• The lancet oncology · Aug 2013

  Comment

  Glioblastoma: bridging the gap with gene therapy.

  no abstract available

  read more… mark as read…

• The lancet oncology · Aug 2013

  Randomized Controlled Trial Multicenter Study

  Docetaxel and atrasentan versus docetaxel and placebo for men with advanced castration-resistant prostate cancer (SWOG S0421): a randomised phase 3 trial.

  The endothelin pathway has a role in bone metastases, which are characteristic of advanced prostate cancer. Atrasentan, an endothelin receptor antagonist, has shown activity in prostate cancer. We therefore assessed its effect on survival in patients with castration-resistant prostate cancer with bone metastases. ⋯ National Cancer Institute, Sanofi-Aventis, and Abbott Laboratories.

  expand abstract… or not…

• The lancet oncology · Aug 2013

  Comment

  Air pollution: another cause of lung cancer.

  no abstract available

  expand abstract… mark as read…